The prescription comes before the cart
The order starts with a clinician who can prescribe in your state. That visit can be in person. It can also be telehealth, when a licensed clinician evaluates the history and the current medicines and then issues the prescription. A checkbox that drops gabapentin into a cart is not that visit.
A pharmacy operating legally, in the FDA's account, always requires a doctor's prescription, lists a physical address and telephone number in the United States, has a licensed pharmacist who can answer questions, and is licensed with a state board of pharmacy. The prescription and the pharmacy are separate steps. A clinician can send the order to a pharmacy you already use, or a telehealth visit can end at a mail-order pharmacy that holds its own state license. The medicine still moves under pharmacy rules.
Look up the pharmacy before paying
An unfamiliar site gets checked before a card number is entered. FDA's page on how to buy medicines safely from an online pharmacy describes legal pharmacies and the sites that skip a prescription, a US license, or a pharmacist, and that often advertise deeply discounted prices. It points readers to BeSafeRx, the FDA hub for online pharmacy information, including a location tool for a state board's license database. If the online pharmacy is not listed, the FDA says not to use it.
The practical question for the pharmacist is narrow: will this pharmacy dispense the written product — Neurontin or generic gabapentin, the form, and the milligram strength — to the address on the prescription? A chat reply is not a license. Medicine that looks different from a usual pharmacy fill, or that arrives broken, in a foreign language, or with no expiration date or an expired date, is one of the FDA's warning signs for an unsafe site.
Neurontin strengths, and the extended-release listing
One checkout screen can fail the order by itself. It lists Neurontin 800 mg, marks the schedule once daily and extended-release, and never asks for a prescription or a creatinine clearance. Immediate-release Neurontin is a different product, and the missing prescription already ends the order.
On the Neurontin label the capsules are 100 mg, 300 mg, and 400 mg. The 100 mg capsule is white, the 300 mg capsule is yellow, and the 400 mg capsule is orange, each printed with “VLE” on the body and “Neurontin” plus the strength on the cap. Tablets are 600 mg and 800 mg: white, elliptical, film-coated, and scored, debossed “NT” and “16” on the 600 mg tablet and “NT” and “26” on the 800 mg tablet. The oral solution is 250 mg per 5 mL (50 mg per mL), clear and colorless to slightly yellow. A generic capsule will not carry the Neurontin print. The pharmacy label still has to name gabapentin and the strength on the prescription.
Usual adult schedules are every day, divided through the day. For partial onset seizures in people 12 years and older, the starting dose is 300 mg three times a day, and the recommended maintenance dose is 300 mg to 600 mg three times a day, using 300 mg or 400 mg capsules or 600 mg or 800 mg tablets. The gap between doses should not exceed 12 hours. Gabapentin's elimination half-life is 5 to 7 hours and does not change with the dose. That clock is elimination time. It explains why a prescription for normal kidney function is spread across the day, and it does not state how long pain relief will last.
For postherpetic neuralgia in adults, the label may start with a single 300 mg dose on day 1, 600 mg on day 2 (300 mg twice), and 900 mg on day 3 (300 mg three times a day), then titrate as needed for pain to 1800 mg/day (600 mg three times a day). Clinical studies showed efficacy from 1800 mg/day to 3600 mg/day, without additional benefit demonstrated above 1800 mg/day. The prescriber who wrote the prescription owns that start.
Neurontin can be taken with or without food. Food has only a slight effect on absorption, about a 14% increase in AUC and peak concentration. Capsules are swallowed whole with water. A scored 600 mg or 800 mg tablet may be split when the prescription calls for a half-tablet: half of 600 mg is 300 mg, and half of 800 mg is 400 mg. The unused half is the next dose. A half-tablet not used within 28 days is discarded. An antacid the label names, Maalox, containing aluminum hydroxide and magnesium hydroxide, reduced mean gabapentin bioavailability by about 20% when taken at the same time. Gabapentin should be taken at least 2 hours after that antacid.
Exposure also does not rise in a straight line if someone orders a higher strength and takes more. Bioavailability is about 60% at 900 mg/day and about 34% at 2400 mg/day, when those totals are given in three divided doses.
| What the checkout shows | What the Neurontin label describes | Decision |
|---|---|---|
| Neurontin or generic immediate-release capsules, 100 mg, 300 mg, or 400 mg | Brand capsules at those strengths. A generic capsule uses the same active ingredient and does not carry the Neurontin print. | Dispense only when the prescription names capsules and that strength. |
| Tablets, 600 mg or 800 mg | Scored film-coated tablets. Brand 600 mg is marked NT 16; brand 800 mg is marked NT 26. | Match the prescription. A half-tablet, if the prescriber ordered a split, is the next dose, and an unused half is discarded after 28 days. |
| Oral solution, 250 mg per 5 mL | 250 mg per 5 mL (50 mg per mL), clear to slightly yellow. | Match the prescription, including when the written dose is not a whole capsule. |
| Once-daily extended-release gabapentin | A different product from immediate-release Neurontin. Once-daily dosing in the Neurontin kidney schedule is a reduced immediate-release regimen for low creatinine clearance. Driving studies cited on this label used gabapentin enacarbil extended-release tablets, a prodrug. The prescription's Neurontin capsules are the immediate-release product. | Do not swap it for an immediate-release prescription. |
| No prescription, a deep discount, a pack with no usable date, or a veterinary or unrelated domain | The FDA's warning pattern for an unsafe online pharmacy: no prescription, no US and state license, no pharmacist, or a price that exists only because those safeguards are missing. | Leave the site. |
A veterinary-clinic website sits in that last row. Ivermectin is a different medicine, and that kind of website is the wrong place to buy it as well.
Opioids, other sedatives, and breathing
Respiratory depression may occur when Neurontin is used with other central nervous system depressants, including opioids, or when breathing is already impaired. The label's evidence is case reports, human studies, and animal studies associating gabapentin with serious, life-threatening, or fatal respiratory depression in those settings. Postmarketing reports include life-threatening and fatal cases. The label's interaction detail names morphine and hydrocodone; oxycodone, buprenorphine, and other opioids sit under the same respiratory-depression warning with CNS depressants.
Gabapentin does not bind opioid receptors (mu, delta, or kappa), benzodiazepine receptors, or cannabinoid 1 receptors. Sedation from Neurontin and from another sedating drug can add together. Morphine can also raise gabapentin exposure: the label cites a report of 12 people in which a 60 mg controlled-release morphine capsule, taken 2 hours before a 600 mg Neurontin capsule, increased mean gabapentin exposure (AUC) by 44%. Morphine's own levels were unchanged in that sequence. The size of the interaction at other doses is unknown. Taking Neurontin with hydrocodone decreases hydrocodone exposure, so starting or stopping Neurontin can change the hydrocodone effect.
Together, the drugs can make breathing too slow or too shallow. That can be fatal. If a clinician still prescribes Neurontin with an opioid or another CNS depressant, or prescribes it for someone with respiratory impairment, the label says to watch for respiratory depression and sedation, to consider a low starting dose, and to manage respiratory depression with close observation, supportive measures, and reduction or withdrawal of the CNS depressants, including Neurontin. An online order that never asks about opioids, other sedatives, or lung disease skips that step. Payment waits until the prescriber has already made the plan.
Extended gabapentin use with opioids close to delivery may increase neonatal withdrawal compared with opioids alone. Pregnancy plus an opioid belongs in the clinician visit.
The ordinary cluster on the label is somnolence, dizziness, ataxia, and fatigue — common enough that epilepsy trials in people older than 12 reported somnolence in about 19% on Neurontin versus 9% on placebo, dizziness in about 17% versus 7%, and ataxia in about 13% versus 6%. In postherpetic neuralgia trials, somnolence reached about 21% versus 5% and dizziness about 28% versus 8%. That ordinary cluster is why driving waits until the person taking Neurontin has enough experience to know whether it impairs driving or the use of heavy machinery. The label says that self-assessment of sleepiness can be imperfect, and that the duration of driving impairment after Neurontin is started is unknown. The driving studies it cites were done with gabapentin enacarbil extended-release tablets. Neurontin capsules are a separate product.
Gabapentin is secreted in human milk after oral doses. Effects on the breastfed infant and on milk production are unknown. The clinician weighs the mother's need for Neurontin against unknown effects on the infant before an online refill is treated as routine.
Other prescriptions do not set this dose. Tizanidine and modafinil have their own labels. The medicine list, including any opioid, goes to the clinician who writes the gabapentin order.
Kidneys, the one-week taper, and the labeled uses
Gabapentin leaves the body through the kidney as unchanged drug. Clearance tracks creatinine clearance, which the label notes can be estimated with the Cockcroft-Gault equation when kidney function is stable. Older adults are more likely to have lower kidney function, so the same milligram strength can mean higher exposure. The dose follows that clearance number. Neurontin in people younger than 12 years with reduced kidney function has not been studied.
For people 12 years and older, the prescriber uses the label's renal schedule:
- Creatinine clearance at least 60 mL/min: 900 to 3600 mg/day, three times a day, as 300, 400, 600, 800, or 1200 mg at each dose.
- Greater than 30 to 59 mL/min: 400 to 1400 mg/day, as 200, 300, 400, 500, or 700 mg twice a day.
- Greater than 15 to 29 mL/min: 200 to 700 mg/day, as 200, 300, 400, 500, or 700 mg once a day. That once-daily line is still immediate-release Neurontin on a reduced schedule.
- 15 mL/min: 100 to 300 mg/day, as 100, 125, 150, 200, or 300 mg once a day. Below 15 mL/min, the daily dose is reduced in proportion. The label's example: at 7.5 mL/min, use half the daily dose used at 15 mL/min.
- Hemodialysis: a maintenance dose based on creatinine clearance, plus a supplemental dose after each 4 hours of hemodialysis. The label's supplemental doses are 125, 150, 200, 250, or 350 mg. In one study of 11 anuric adults, the apparent half-life on days without dialysis was about 132 hours, and during dialysis it fell to about 3.8 hours.
Those figures are the doses at each administration. They are prepared from the capsules, tablets, and solution already on the label. They are not extra capsule strengths. A cart that offers 800 mg three times a day and never asks for creatinine clearance has left this schedule out.
The labeled uses are management of postherpetic neuralgia in adults, and adjunctive therapy for partial onset seizures, with or without secondary generalization, in adults and in pediatric patients 3 years and older. Postherpetic neuralgia is not an established pediatric use. Seizure use under age 3 is not established. Pediatric seizure maintenance on the label is weight-based and divided three times a day: 40 mg/kg/day for ages 3 to 4, and 25 to 35 mg/kg/day for ages 5 to 11, reached by upward titration over about 3 days from a start of 10 to 15 mg/kg/day. The prescription has to already state the milligrams for that weight-based schedule. A storefront selling gabapentin for anxiety or depression is outside these labeled indications. When a clinician has prescribed Neurontin for any reason, the suicidality warning still applies.
Antiepileptic drugs, including Neurontin, increase the risk of suicidal thoughts or behavior. In pooled trials the adjusted relative risk was 1.8 versus placebo. Across a median of 12 weeks, suicidal behavior or ideation occurred in 0.43% of 27,863 people treated with an antiepileptic drug and in 0.24% of 16,029 people on placebo, about one additional case for every 530 people treated. The increase can appear in the first week. Four suicides occurred among people on drug in those trials and none on placebo, a count too small to settle the effect on suicide itself. Caregivers watch for new or worse depression, unusual changes in mood or behavior, or thoughts of self-harm, and report them to a clinician immediately. The same warning covers the period after Neurontin is stopped.
If the dose is reduced, discontinued, or substituted with another medicine, it should be done gradually over a minimum of 1 week. The prescriber may choose a longer taper. Stopping abruptly can raise seizure risk. Withdrawal symptoms may start within 48 hours and have included seizures, depression, suicidal ideation and behavior, agitation, confusion, disorientation, anxiety, insomnia, nausea, pain, sweating, tremor, headache, dizziness, and malaise. A late shipment still waits for that taper.
Two reactions matter the first time a mailed bottle is opened. Anaphylaxis and angioedema can follow the first dose or appear later: difficulty breathing, swelling of the lips, throat, and tongue, and low blood pressure. Neurontin is stopped and emergency care is the next step. A severe multiorgan hypersensitivity, drug reaction with eosinophilia and systemic symptoms, has occurred with Neurontin and has been fatal. Fever, rash, or swollen lymph nodes needs immediate evaluation. Neurontin is contraindicated after a known hypersensitivity to gabapentin or its ingredients.
Suspected adverse reactions can be reported to the manufacturer number printed on the Neurontin label, Viatris at 1-877-446-3679, or to FDA MedWatch at 1-800-FDA-1088.
Neurontin versus generic, and the discount that skips the prescription
A licensed pharmacy's quote moves with facts on the prescription: Neurontin or generic gabapentin, capsules or tablets or the 250 mg/5 mL solution, and the quantity to dispense. Insurance and the pharmacy's own cash price change the figure again.
A low price that shows up only because the site does not require a prescription is the FDA's unsafe pattern. The quote worth comparing is the one a licensed pharmacy gives after it has the prescription. Unlawful internet sales can be reported to the FDA. That report is separate from MedWatch, which is for an unexpected reaction to a medicine.
Checks that have to be true before payment
- A clinician has written gabapentin or Neurontin, including the form, the strength, and the daily schedule. Telehealth counts only when that clinician issued the prescription.
- The pharmacy is licensed in the United States and in your state. The license is checked with FDA BeSafeRx and the state board. The site lists a US address and phone, and a pharmacist can be reached.
- The cart matches the prescription: capsules of 100 mg, 300 mg, or 400 mg; tablets of 600 mg or 800 mg; or solution at 250 mg per 5 mL. Immediate-release Neurontin stays on the order when the prescription is immediate-release.
- Opioids, other CNS depressants, and any breathing problem are already in the clinician's plan. If they are not, payment stops.
- Creatinine clearance was used to set the dose, including for an older adult. The prescriber applies the kidney schedule.
- Any stop, cut, or substitution waits for the prescriber. The label's minimum taper is one week, including when a shipment is late.
- The site requires the prescription. A no-prescription price, a veterinary or unrelated domain, or a package with no usable date ends the checkout.
- A caregiver knows to watch for mood changes. Antiepileptic drugs, including Neurontin, raise the risk of suicidal thoughts or behavior for any indication, in the first week and after a stop.
- There is no prior hypersensitivity to gabapentin. Swelling of the lips, throat, or tongue, or trouble breathing after a dose, is emergency care.